NCT05901441View on ClinicalTrials.gov

Effect of Epidural Hydromorphone Combined With Ropivacaine in Labor Analgesia

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
AnalgesiaLabor Pain
Interventions
DRUG

Hydromorphone

For those in H1 group: they will be administered with15 ug/ml hydromorphone, For those in H2 group: they will be administered with17.5 ug/ml hydromorphone , For those in H3 group: they will be administered with 20 ug/ml hydromorphone

DRUG

Sufentanil

For those in SF group: they will be administered with 40 ug/ml sufentanil

DRUG

Ropivacaine

0.08% ropivacaine will be co-administrated for epidural labor analgesia in four arms

Trial Locations (1)

430000

Maternal and Child Health Hospital of Hubei Province, Wuhan

All Listed Sponsors
lead

Maternal and Child Health Hospital of Hubei Province

OTHER